Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 1S10OD025235-01
10X Genomics Chromium Single-cell Sequencing to Expand Research At Dartmouth
National Institutes of Health
Grant: 3P30CA023108-41S8
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA216265-05
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
National Institutes of Health
Grant: 5R01GM122846-02
Defining human kinase-substrate networks and their dynamic regulation
National Institutes of Health
Grant: 5R00CA201574-05
Exploiting the epithelial-to-mesenchymal transition for the differentiation of cancer stem cells
National Institutes of Health
Grant: 5R01CA267691-04
Uncovering the basis and implications of lineage plasticity in breast cancer
National Institutes of Health
Grant: 3P20GM130454-05S2
NOSI cloud computing Supplement
NCI NIH HHS
Grant: R00 CA201574
NIGMS NIH HHS
Grant: P20 GM130454
NIH HHS
Grant: S10 OD025235
NCI NIH HHS
Grant: P30 CA023108
NCI NIH HHS
Grant: R01 CA216265
NIGMS NIH HHS
Grant: R01 GM122846
NCI NIH HHS
Grant: R01 CA267691
Fields of Study
Keywords
Sustainable Development Goals